tradingkey.logo
๎™ผ
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™

BioMarin Pharmaceutical Inc

BMRN
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
63.940USD
-1.140-1.75%
์ข…๊ฐ€ย 09-18 16:00๏ผˆET๏ผ‰
12.39B์‹œ๊ฐ€์ด์•ก
45.89P/E TTM

BMRN ์žฌ๋ฌด ๋ฐ์ดํ„ฐ

์Šค๋งˆํŠธํ•œ ํˆฌ์ž์ž๋ฅผ ์œ„ํ•ด ์„ค๊ณ„๋œ ์˜ฌ์ธ์› ๋ฐ์ดํ„ฐ ๋Œ€์‹œ๋ณด๋“œ๋ฅผ ํ†ตํ•ด BioMarin Pharmaceutical Inc์˜ ์žฌ๋ฌด ๋ฐ์ดํ„ฐ๋ฅผ ํ™•์ธํ•˜์„ธ์š”. ๋ณต์žกํ•œ ์žฌ๋ฌด์ œํ‘œ๋ฅผ ์‚ฌ์šฉ์ž ์ •์˜ ๊ฐ€๋Šฅํ•œ ๋ทฐ๋กœ ๊ตฌ์„ฑํ•˜์—ฌ ์žฌ๋ฌด ๋ถ„์„์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ์ตœ์‹  ์—ฐ๊ฐ„ ์žฌ๋ฌด ๋ณด๊ณ ์„œ์— ์ ‘๊ทผํ•˜๊ฑฐ๋‚˜, ์†์ต๊ณ„์‚ฐ์„œ, ์žฌ๋ฌด์ƒํƒœํ‘œ, ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ๋ถ„๊ธฐ๋ณ„ ์„ฑ๊ณผ๋ฅผ ๋ถ„์„ํ•˜์„ธ์š”. ์‹ค์‹œ๊ฐ„ ์žฌ๋ฌด ์ง€ํ‘œ๋ฅผ ์†๋์—์„œ ํ™•์ธํ•  ์ˆ˜ ์žˆ์–ด ํšŒ์‚ฌ์˜ ์‹œ์žฅ ๊ฑด์ „์„ฑ์„ ์‹œ๊ฐ„์— ๋”ฐ๋ผ ๊ทธ ์–ด๋А ๋•Œ๋ณด๋‹ค ์‰ฝ๊ฒŒ ๋ชจ๋‹ˆํ„ฐ๋งํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

ํ•ต์‹ฌ ์žฌ๋ฌด ๋น„์œจ

์‹œ๊ฐ€์ด์•ก
12.39B
๋ฐฐ๋‹น ์ˆ˜์ต๋ฅ 
0.00
P/E TTM
45.89
์ฃผ๋‹น์ˆœ์ด์ต
1.40
์ˆ˜์ต
3.22B
์ˆœ์ด์ต
426.86M
ROE
4.48%
ROA
3.42%

BioMarin Pharmaceutical Inc ์‹ค์  ๋ฐœํ‘œ์ผ๎˜

์ตœ์‹  ์ถœ์‹œ
Aug 6, 2026
EPS / ์˜ˆ์ƒ
0.23/0.69
์ˆ˜์ต / ์˜ˆ์ƒ
989.71M/926.91M

์žฌ๋ฌด์ œํ‘œ ์š”์•ฝ

๋ถ„๊ธฐ๋ณ„๎˜ฎ
๋ถ„๊ธฐ๋ณ„+์—ฐ๊ฐ„
๋ถ„๊ธฐ๋ณ„
์—ฐ๊ฐ„
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
์žฌ๋ฌด ์ง€ํ‘œ
EPS
-81.54%0.23
-43.62%0.55
-136.98%-0.24
-128.74%-0.16
122.33%1.25
107.13%0.97
506.12%0.66
159.67%0.56
89.07%0.56
72.32%0.47
8167.16%0.11
--0.21
--0.30
--0.27
--0.00
--0.77
----
----
----
----
์ˆ˜์ต
19.91%989.71M
2.83%766.21M
17.03%874.57M
4.08%776.13M
15.92%825.41M
14.84%745.14M
15.65%747.31M
28.28%745.74M
19.61%712.03M
8.79%648.83M
20.22%646.21M
15.04%581.33M
11.52%595.27M
14.84%596.41M
19.50%537.54M
23.63%505.34M
6.40%533.80M
6.86%519.36M
-0.51%449.81M
-14.27%408.74M
์ˆœ์ด์ต
-81.39%44.76M
-43.17%105.53M
-137.28%-46.57M
-128.98%-30.74M
124.43%240.53M
109.43%185.69M
513.22%124.94M
162.72%106.08M
91.25%107.17M
74.35%88.66M
8282.73%20.38M
707.01%40.38M
102.57%56.04M
-57.90%50.85M
99.57%-249.00K
81.77%-6.65M
113.77%27.66M
595.40%120.80M
-361.99%-57.90M
-104.65%-36.49M
์ˆœ์ด์ต๋ฅ 
-84.48%4.52%
-44.73%13.77%
-131.85%-5.33%
-127.85%-3.96%
93.60%29.14%
82.36%24.92%
430.25%16.72%
104.80%14.22%
59.89%15.05%
60.27%13.66%
6907.02%3.15%
--6.95%
--9.41%
--8.53%
---0.05%
--9.10%
----
----
----
----
์ด ์ด์ต๋ฅ 
-11.26%72.08%
-6.39%73.97%
1.32%81.55%
9.82%81.33%
1.96%81.23%
0.65%79.01%
5.50%80.49%
-1.62%74.06%
5.62%79.67%
3.09%78.50%
9.47%76.30%
--75.28%
--75.43%
--76.15%
--69.69%
--74.11%
----
----
----
----
๋ถ€์ฑ„๋น„์œจ
346.60%35.71%
99.76%16.65%
-7.82%7.86%
-9.72%7.84%
-48.11%8.00%
-47.35%8.33%
-46.41%8.52%
-45.99%8.68%
-6.79%15.41%
-6.05%15.83%
-6.67%15.89%
--16.07%
--16.53%
--16.85%
--17.03%
--17.27%
----
----
----
----
์ˆ˜์ต
19.91%989.71M
2.83%766.21M
17.03%874.57M
4.08%776.13M
15.92%825.41M
14.84%745.14M
15.65%747.31M
28.28%745.74M
19.61%712.03M
8.79%648.83M
20.22%646.21M
15.04%581.33M
11.52%595.27M
14.84%596.41M
19.50%537.54M
23.63%505.34M
6.40%533.80M
6.86%519.36M
-0.51%449.81M
-14.27%408.74M
์˜์—… ์ด์ต
-39.56%167.34M
-38.39%137.94M
14.83%196.64M
-129.66%-46.69M
73.62%276.89M
185.35%223.89M
527.75%171.25M
415.70%157.42M
143.23%159.48M
27.75%78.46M
308.43%27.28M
2150.03%30.52M
63.72%65.57M
95.98%61.42M
79.61%-13.09M
97.10%-1.49M
188.88%40.05M
14.29%31.34M
-98.65%-64.19M
11.66%-51.40M
์ˆœ์ด์ต
-81.39%44.76M
-43.17%105.53M
-137.28%-46.57M
-128.98%-30.74M
124.43%240.53M
109.43%185.69M
513.22%124.94M
162.72%106.08M
91.25%107.17M
74.35%88.66M
8282.73%20.38M
707.01%40.38M
102.57%56.04M
-57.90%50.85M
99.57%-249.00K
81.77%-6.65M
113.77%27.66M
595.40%120.80M
-361.99%-57.90M
-104.65%-36.49M
์œ ๋™์ž์‚ฐ
4.37%3.97B
32.79%4.61B
22.31%3.95B
26.11%3.85B
16.74%3.81B
16.18%3.47B
9.35%3.23B
3.43%3.06B
10.49%3.26B
5.03%2.99B
7.44%2.96B
10.16%2.96B
17.18%2.95B
18.72%2.84B
20.98%2.75B
16.06%2.68B
6.78%2.52B
4.60%2.39B
-2.90%2.27B
-15.60%2.31B
์œ ๋™ ๋ถ€์ฑ„ ์ด๊ณ„
143.19%1.66B
26.26%793.15M
25.05%759.03M
11.57%798.44M
-35.89%684.25M
-42.25%628.21M
-48.43%606.99M
-38.48%715.66M
78.71%1.07B
81.85%1.09B
99.87%1.18B
123.26%1.16B
28.51%597.23M
21.98%598.23M
9.09%588.88M
1.19%521.02M
4.82%464.73M
14.04%490.42M
9.60%539.82M
-39.76%514.90M
์ด ์ž์‚ฐ
57.23%11.72B
20.20%8.59B
8.66%7.59B
11.15%7.61B
5.51%7.46B
3.99%7.15B
2.15%6.99B
1.38%6.85B
7.68%7.07B
6.82%6.87B
7.32%6.84B
7.89%6.76B
6.79%6.56B
6.12%6.43B
6.19%6.38B
4.79%6.26B
4.19%6.15B
4.44%6.06B
2.66%6.00B
-2.93%5.98B
๋ถ€์ฑ„ ์ด๊ณ„
277.95%5.40B
75.75%2.38B
13.23%1.51B
8.37%1.56B
-19.74%1.43B
-24.76%1.35B
-29.58%1.33B
-22.75%1.44B
0.03%1.78B
1.36%1.80B
6.67%1.89B
9.78%1.86B
8.49%1.78B
6.18%1.77B
2.27%1.77B
-0.92%1.70B
-0.96%1.64B
1.73%1.67B
-0.54%1.73B
-18.67%1.71B
์ž๋ณธ ์ด๊ณ„
4.89%6.32B
7.23%6.21B
7.58%6.09B
11.88%6.06B
14.01%6.03B
14.18%5.79B
14.27%5.66B
10.55%5.41B
10.53%5.29B
8.90%5.07B
7.57%4.95B
7.19%4.90B
6.17%4.78B
6.10%4.66B
7.78%4.60B
7.09%4.57B
6.21%4.50B
5.51%4.39B
4.01%4.27B
5.24%4.27B
์ˆœ์˜์—…์ด์ต
-9.26%168.11M
26.52%220.65M
-46.32%99.64M
66.46%368.69M
56.00%185.27M
271.28%174.39M
575.42%185.63M
63.28%221.48M
69.51%118.76M
163.53%46.97M
305.00%27.48M
-14.32%135.65M
24.61%70.06M
-62.73%-73.93M
-39.30%6.79M
63.12%158.32M
-32.08%56.23M
-140.02%-45.43M
183.53%11.18M
12.59%97.06M
์ˆœํˆฌ์ž
-40416.83%-5.10B
2669.33%725.53M
-155.56%-42.45M
-1948.42%-330.96M
-113.92%-12.59M
-98.36%-28.24M
217.61%76.40M
64.72%-16.16M
206.40%90.48M
52.57%-14.24M
-18.74%-64.96M
-95.71%-45.80M
199.43%29.53M
-134.19%-30.01M
1.28%-54.71M
80.47%-23.40M
75.30%-29.70M
224.01%87.78M
-602.59%-55.42M
-212.32%-119.85M
์ˆœ์žฌ๋ฌดํ™œ๋™
59591.20%2.74B
2196.93%813.17M
10.42%3.16M
99.57%-2.17M
-136.50%-4.60M
9.38%-38.78M
-73.63%2.86M
-63240.74%-499.13M
5.43%12.61M
-5.03%-42.79M
-0.27%10.84M
-110.45%-788.00K
201.55%11.96M
-61.16%-40.74M
-24.50%10.87M
831.43%7.54M
-207.57%-11.78M
-3.76%-25.28M
103.93%14.40M
-131.66%-1.03M

์ˆ˜์ต๎˜

์‚ฌ์—…๋ณ„

์ฃผ๊ธฐ:
๋ฐ์ดํ„ฐ ์—†์Œ

์ง€์—ญ๋ณ„

์ฃผ๊ธฐ:
๋ฐ์ดํ„ฐ ์—†์Œ

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

BioMarin Pharmaceutical Inc์˜ ์ด์ˆ˜์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
BioMarin Pharmaceutical Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋งค์ถœ์€ 3.22B์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 2.85B์ž…๋‹ˆ๋‹ค.

BioMarin Pharmaceutical Inc์˜ ์œ ๋™์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
BioMarin Pharmaceutical Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์œ ๋™์ž์‚ฐ์€ 3.95B์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 22.31์ž…๋‹ˆ๋‹ค.

BioMarin Pharmaceutical Inc์˜ ์ด์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
BioMarin Pharmaceutical Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, BioMarin Pharmaceutical Inc์˜ ์ด์ž์‚ฐ์€ 7.59B์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 8.66์ž…๋‹ˆ๋‹ค.

BioMarin Pharmaceutical Inc์˜ ์ด๋ถ€์ฑ„๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
BioMarin Pharmaceutical Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, BioMarin Pharmaceutical Inc์˜ ์ด๋ถ€์ฑ„๋Š” 1.51B์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 13.23์ž…๋‹ˆ๋‹ค.

BioMarin Pharmaceutical Inc์˜ ์ด์ž๋ณธ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
BioMarin Pharmaceutical Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, BioMarin Pharmaceutical Inc์˜ ์ด์ž๋ณธ์€ 6.09B์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 7.58์ž…๋‹ˆ๋‹ค.

BioMarin Pharmaceutical Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
BioMarin Pharmaceutical Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, BioMarin Pharmaceutical Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ 871.73M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 52.92์ž…๋‹ˆ๋‹ค.

BioMarin Pharmaceutical Inc์˜ ์ˆœํˆฌ์ž๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
BioMarin Pharmaceutical Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, BioMarin Pharmaceutical Inc์˜ ์ˆœํˆฌ์ž๋Š” -414.24M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -403.49์ž…๋‹ˆ๋‹ค.

BioMarin Pharmaceutical Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
BioMarin Pharmaceutical Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, BioMarin Pharmaceutical Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ -42.39M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 91.95์ž…๋‹ˆ๋‹ค.

BioMarin Pharmaceutical Inc์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
BioMarin Pharmaceutical Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ 1.82์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -19.01์ž…๋‹ˆ๋‹ค.

BioMarin Pharmaceutical Inc์˜ ์ˆœ์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
BioMarin Pharmaceutical Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต์€ 348.90M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -18.26์ž…๋‹ˆ๋‹ค.

BioMarin Pharmaceutical Inc์˜ ์ˆœ์ด์ต๋ฅ ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
BioMarin Pharmaceutical Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต๋ฅ ์€ 10.83์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -27.58์ž…๋‹ˆ๋‹ค.

BioMarin Pharmaceutical Inc์˜ ๋งค์ถœ์ด์ด์ต๋ฅ ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
BioMarin Pharmaceutical Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋งค์ถœ์ด์ด์ต๋ฅ ์€ 80.83์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 3.42์ž…๋‹ˆ๋‹ค.

BioMarin Pharmaceutical Inc์˜ ๋ถ€์ฑ„/์ž์‚ฐ ๋น„์œจ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
BioMarin Pharmaceutical Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋ถ€์ฑ„/์ž์‚ฐ ๋น„์œจ์€ 7.87์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -7.74์ž…๋‹ˆ๋‹ค.

BioMarin Pharmaceutical Inc์˜ ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
BioMarin Pharmaceutical Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ 5.94์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -26.17์ž…๋‹ˆ๋‹ค.

BioMarin Pharmaceutical Inc์˜ ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
BioMarin Pharmaceutical Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ 4.79์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -22.48์ž…๋‹ˆ๋‹ค.

BioMarin Pharmaceutical Inc์˜ ์˜์—…์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
BioMarin Pharmaceutical Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์˜์—…์ด์ต์€ 871.73M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 52.92์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ